(Reuters) – AstraZeneca could start profiting from its COVID-19 vaccine as soon as July next year, the Financial Times reported on Wednesday, citing a memo showing the British drugmaker can declare when it considers the pandemic to have ended.
The London-listed firm previously said it would not profit from the vaccine “during the pandemic”, and the report attributes the development to a memorandum of understanding signed this year between AstraZeneca and Brazil’s Fiocruz. (https://on.ft.com/3lgC0Xo)
AstraZeneca did not immediately respond to a Reuters request for comment.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)
